Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Osteoporosis International
Erschienen in: Osteoporosis International 10/2023

02.07.2023 | Review

Melatonin and bone-related diseases: an updated mechanistic overview of current evidence and future prospects

verfasst von: Abolfazl Bagherifard, Azam Hosseinzadeh, Fereshteh Koosha, Mohammad Sheibani, Arman Karimi-Behnagh, Russel J. Reiter, Saeed Mehrzadi

Erschienen in: Osteoporosis International | Ausgabe 10/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Bone diseases account for an enormous cost burden on health systems. Bone disorders are considered as age-dependent diseases. The aging of world population has encouraged scientists to further explore the most effective preventive modalities and therapeutic strategies to overcome and reduce the high cost of bone disorders. Herein, we review the current evidence of melatonin’s therapeutic effects on bone-related diseases.

Methods

This review summarized evidences from in vitro, in vivo, and clinical studies regarding the effects of melatonin on bone-related diseases, with a focus on the molecular mechanisms. Electronically, Scopus and MEDLINE®/PubMed databases were searched for articles published on melatonin and bone-related diseases from inception to June 2023.

Results

The findings demonstrated that melatonin has beneficial effect in bone- and cartilage-related disorders such as osteoporosis, bone fracture healing, osteoarthritis, and rheumatoid arthritis, in addition to the control of sleep and circadian rhythms.

Conclusion

A number of animal and clinical studies have indicated that various biological effects of melatonin may suggest this molecule as an effective therapeutic agent for controlling, diminishing, or suppressing bone-related disorders. Therefore, further clinical studies are required to clarify whether melatonin can be effective in patients with bone-related diseases.
Literatur
1.
Acuna-Castroviejo D, Escames G, Reiter R (2006) Melatonin therapy in fibromyalgia. J Pineal Res 40:98–99PubMedCrossRef
2.
Acuña-Castroviejo D, Escames G, Venegas C et al (2014) Extrapineal melatonin: sources, regulation, and potential functions. Cell Mol Life Sci 71:2997–3025PubMedCrossRef
3.
Altındal D, Gümüşderelioğlu M (2016) Melatonin releasing PLGA micro/nanoparticles and their effect on osteosarcoma cells. J Microencapsul 33:53–63PubMedCrossRef
4.
Amstrup AK, Sikjaer T, Heickendorff L et al (2015) Melatonin improves bone mineral density at the femoral neck in postmenopausal women with osteopenia: a randomized controlled trial. J Pineal Res 59:221–229PubMedCrossRef
5.
Amstrup AK, Sikjaer T, Mosekilde L et al (2015) The effect of melatonin treatment on postural stability, muscle strength, and quality of life and sleep in postmenopausal women: a randomized controlled trial. Nutr J 14:102PubMedPubMedCentralCrossRef
6.
Anderson G, Maes M (2020) Mitochondria and immunity in chronic fatigue syndrome. Prog Neuropsychopharmacol Biol Psychiatry 103:109976PubMedCrossRef
7.
Arushanian ÉB, Naumov SS, Ivanova VN et al (2014) Comparative study of the influence of melatonin and diclofenac on some hematologic indices of experimental rheumatoid arthritis in rats. Eksp Klin Farmakol 77:13–15PubMed
8.
Ballur AFH, Altinoz E, Yigitturk G et al (2022) Influence of pinealectomy and long-term melatonin administration on inflammation and oxidative stress in experimental gouty arthritis. Inflammation 45:1332–1347PubMedCrossRef
9.
Bang J, Chang HW, Jung HR et al (2012) Melatonin attenuates clock gene cryptochrome1, which may aggravate mouse anti-type II collagen antibody-induced arthritis. Rheumatol Int 32:379–385PubMedCrossRef
10.
Benitez-King G, Anton-Tay F (1993) Calmodulin mediates melatonin cytoskeletal effects. Experientia 49:635–641PubMedCrossRef
11.
12.
Body JJ, Quinn G, Talbot S et al (2017) Systematic review and meta-analysis on the proportion of patients with breast cancer who develop bone metastases. Crit Rev Oncol Hematol 115:67–80PubMedCrossRef
13.
Bruno A, Micò U, Lorusso S et al (2013) Agomelatine in the treatment of fibromyalgia: a 12-week, open-label, uncontrolled preliminary study. J Clin Psychopharmacol 33:507–511PubMedCrossRef
14.
15.
Bubenik GA (2002) Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 47:2336–2348PubMedCrossRef
16.
Burgess HJ, Park M, Ong JC et al (2017) Morning versus evening bright light treatment at home to improve function and pain sensitivity for women with fibromyalgia: a pilot study. Pain Med 18:116–123PubMedCrossRef
17.
Calandre E, Slim M, Garcia-Leiva J et al (2014) Agomelatine for the treatment of patients with fibromyalgia and depressive symptomatology: an uncontrolled, 12-week, pilot study. Pharmacopsychiatry 47:67–72PubMedCrossRef
18.
19.
Caramés B, Taniguchi N, Otsuki S et al (2010) Autophagy is a protective mechanism in normal cartilage, and its aging-related loss is linked with cell death and osteoarthritis. Arthritis Rheum 62:791–801PubMedPubMedCentralCrossRef
20.
Casado-Zapico S, Rodriguez-Blanco J, García-Santos G et al (2010) Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway. J Pineal Res 48:72–80PubMedCrossRef
21.
Castaño MY, Garrido M, Delgado-Adámez J et al (2018) Oral melatonin administration improves the objective and subjective sleep quality, increases 6-sulfatoxymelatonin levels and total antioxidant capacity in patients with fibromyalgia. J Appl Biomed 16:186–191CrossRef
22.
Castaño MY, Garrido M, Rodríguez AB et al (2019) Melatonin improves mood status and quality of life and decreases cortisol levels in fibromyalgia. Biol Res Nurs 21:22–29PubMedCrossRef
23.
Caumo W, Hidalgo MP, Souza A et al (2019) Melatonin is a biomarker of circadian dysregulation and is correlated with major depression and fibromyalgia symptom severity. J Pain Res 12:545PubMedPubMedCentralCrossRef
24.
Chan Y-H, Ho K-N, Lee Y-C et al (2022) Melatonin enhances osteogenic differentiation of dental pulp mesenchymal stem cells by regulating MAPK pathways and promotes the efficiency of bone regeneration in calvarial bone defects. Stem Cell Res Ther 13:73PubMedPubMedCentralCrossRef
25.
Chen F, Liu H, Wang X et al (2020) Melatonin activates autophagy via the NF-κB signaling pathway to prevent extracellular matrix degeneration in intervertebral disc. Osteoarthritis Cartilage 28:1121–1132PubMedCrossRef
26.
Chen W, Chen X, Chen AC et al (2020) Melatonin restores the osteoporosis-impaired osteogenic potential of bone marrow mesenchymal stem cells by preserving SIRT1-mediated intracellular antioxidant properties. Free Radical Biol Med 146:92–106CrossRef
27.
Chen W, Lv N, Liu H et al (2022) Melatonin improves the resistance of oxidative stress-induced cellular senescence in osteoporotic bone marrow mesenchymal stem cells. Oxid Med Cell Longev 2022:7420726PubMedPubMedCentral
28.
Chen X, Wang Z, Duan N et al (2018) Osteoblast-osteoclast interactions. Connect Tissue Res 59:99–107PubMedCrossRef
29.
Chen Y, Zhang T, Liu X et al (2020) Melatonin suppresses epithelial-to-mesenchymal transition in the MG-63 cell line. Mol Med Rep 21:1356–1364PubMed
30.
Chen Z, Zhao C, Liu P et al (2021) Anti-apoptosis and autophagy effects of melatonin protect rat chondrocytes against oxidative stress via regulation of AMPK/Foxo3 pathways. Cartilage 13:1041s–1053sPubMedPubMedCentralCrossRef
31.
Cheng Y, Cai L, Jiang P et al (2013) SIRT1 inhibition by melatonin exerts antitumor activity in human osteosarcoma cells. Eur J Pharmacol 715:219–229PubMedCrossRef
32.
Chin H, Kim J (2015) Bone metastasis: concise overview. Fed Pract 32:24–30
33.
Choi JH, Jang AR, Park MJ et al (2021) Melatonin inhibits osteoclastogenesis and bone loss in ovariectomized mice by regulating PRMT1-mediated signaling. Endocrinology 162:bqab057
34.
Chu ZM, Li HB, Sun SX et al (2017) Melatonin promotes osteoblast differentiation of bone marrow mesenchymal stem cells in aged rats. Eur Rev Med Pharmacol Sci 21:4446–4456PubMed
35.
Cipriano E, Ceccarelli F, Massaro L et al (2015) Joint involvement in patients affected by systemic lupus erythematosus: application of the swollen to tender joint count ratio. Reumatismo 67:62–67PubMedCrossRef
36.
Citera G, Arias M, Maldonado-Cocco J et al (2000) The effect of melatonin in patients with fibromyalgia: a pilot study. Clin Rheumatol 19:9–13PubMedCrossRef
37.
Cojocaru M, Cojocaru IM, Silosi I et al (2011) Manifestations of systemic lupus erythematosus. Maedica 6:330–336PubMedPubMedCentral
38.
Cutolo M, Villaggio B, Candido F et al (1999) Melatonin influences interleukin-12 and nitric oxide production by primary cultures of rheumatoid synovial macrophages and THP-1 cells. Ann N Y Acad Sci 876:246–254PubMedCrossRef
39.
Da W, Tao L, Wen K et al (2020) Protective role of melatonin against postmenopausal bone loss via enhancement of citrate secretion from osteoblasts. Front Pharmacol 11:667PubMedPubMedCentralCrossRef
40.
Dave M, Attur M, Palmer G et al (2008) The antioxidant resveratrol protects against chondrocyte apoptosis via effects on mitochondrial polarization and ATP production. Arthritis Rheum 58:2786–2797PubMedCrossRef
41.
Day TF, Guo X, Garrett-Beal L et al (2005) Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8:739–750PubMedCrossRef
42.
De Zanette SA, Vercelino R, Laste G et al (2014) Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: a phase II, randomized, double-dummy, controlled trial. BMC Pharmacol Toxicol 15:1–14CrossRef
43.
Dehdashtian E, Mehrzadi S, Yousefi B et al (2018) Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress. Life Sci 193:20–33PubMedCrossRef
44.
Dehlin M, Jacobsson L, Roddy E (2020) Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol 16:380–390PubMedCrossRef
45.
Delmas PD, Ensrud KE, Adachi JD et al (2002) Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. J Clin Endocrinol Metab 87:3609–3617PubMedCrossRef
46.
Deng Z-L, Sharff KA, Tang N et al (2008) Regulation of osteogenic differentiation during skeletal development. FBL 13:2001–2021
47.
Di Carlo FS, Whyte MP, Gianfrancesco F (2020) The two faces of giant cell tumor of bone. Cancer Lett 489:1–8CrossRef
48.
Di Stefano A, Paulesu L (1994) Inhibitory effect of melatonin on production of IFNγ or TNFα in peripheral blood mononuclear cells of some blood donors. J Pineal Res 17:164–169PubMedCrossRef
49.
50.
Dong P, Gu X, Zhu G et al (2018) Melatonin induces osteoblastic differentiation of mesenchymal stem cells and promotes fracture healing in a rat model of femoral fracture via neuropeptide Y/neuropeptide Y receptor Y1 signaling. Pharmacology 102:272–280PubMedCrossRef
51.
Dudek M, Gossan N, Yang N et al (2016) The chondrocyte clock gene Bmal1 controls cartilage homeostasis and integrity. J Clin Investig 126:365–376PubMedCrossRef
52.
Ebisawa T, Karne S, Lerner MR et al (1994) Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc Natl Acad Sci USA 91:6133–6137PubMedPubMedCentralCrossRef
53.
Egermann M, Gerhardt C, Barth A et al (2011) Pinealectomy affects bone mineral density and structure-an experimental study in sheep. BMC Musculoskelet Disord 12:1–9CrossRef
54.
55.
Ekmekcioglu C (2006) Melatonin receptors in humans: biological role and clinical relevance. Biomed Pharmacother = Biomedecine Pharmacotherapie 60:97–108PubMedCrossRef
56.
El-Awady HM, El-Wakkad AS, Saleh MT et al (2007) Serum melatonin in juvenile rheumatoid arthritis: correlation with disease activity. Pak J Biol Sci : PJBS 10:1471–1476PubMedCrossRef
57.
Erdem M, Gülabi D, Aşçı M et al (2014) The effects of melatonin and caffeic acid phenethyl ester (CAPE) on fracture healing under ischemic conditions. Acta Orthop Traumatol Turc 48:339–345PubMedCrossRef
58.
Esalatmanesh K, Loghman A, Esalatmanesh R et al (2021) Effects of melatonin supplementation on disease activity, oxidative stress, inflammatory, and metabolic parameters in patients with rheumatoid arthritis: a randomized double-blind placebo-controlled trial. Clin Rheumatol 40:3591–3597PubMedCrossRef
59.
60.
Favero G, Bonomini F, Franco C et al (2019) Mitochondrial dysfunction in skeletal muscle of a fibromyalgia model: the potential benefits of melatonin. Int J Mol Sci 20:765
61.
Favero G, Trapletti V, Bonomini F et al (2017) Oral supplementation of melatonin protects against fibromyalgia-related skeletal muscle alterations in reserpine-induced myalgia rats. Int J Mol Sci 18:1389PubMedPubMedCentralCrossRef
62.
Feskanich D, Hankinson SE, Schernhammer ES (2009) Nightshift work and fracture risk: the Nurses’ Health Study. Osteoporosis Int: J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA 20:537–542CrossRef
63.
Finkel T, Holbrook NJ (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408:239–247PubMedCrossRef
64.
Fjaerli O, Lund T, Osterud B (1999) The effect of melatonin on cellular activation processes in human blood. J Pineal Res 26:50–55PubMedCrossRef
65.
Forrest CM, Mackay GM, Stoy N et al (2007) Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin. Br J Clin Pharmacol 64:517–526PubMedPubMedCentralCrossRef
66.
Franceschi C, Garagnani P, Morsiani C et al (2018) The continuum of aging and age-related diseases: common mechanisms but different rates. Front Med 5:61CrossRef
67.
Frisher M, Gibbons N, Bashford J et al (2016) Melatonin, hypnotics and their association with fracture: a matched cohort study. Age Ageing 45:801–806PubMedCrossRef
68.
Fusco R, Siracusa R, D’amico R et al (2019) Melatonin plus folic acid treatment ameliorates reserpine-induced fibromyalgia: an evaluation of pain, oxidative stress, and inflammation. Antioxidants 8:628PubMedPubMedCentralCrossRef
69.
Gagarina V, Gabay O, Dvir-Ginzberg M et al (2010) SirT1 enhances survival of human osteoarthritic chondrocytes by repressing protein tyrosine phosphatase 1B and activating the insulin-like growth factor receptor pathway. Arthritis Rheum 62:1383–1392PubMedPubMedCentralCrossRef
70.
Gao B, Gao W, Wu Z et al (2018) Melatonin rescued interleukin 1β-impaired chondrogenesis of human mesenchymal stem cells. Stem Cell Res Ther 9:162PubMedPubMedCentralCrossRef
71.
Gao Q, Zhou L, Yang S-Y et al (2016) A novel role of microRNA 17–5p in the modulation of circadian rhythm. Sci Rep 6:1–12
72.
73.
Gao W, Lin M, Liang A et al (2014) Melatonin enhances chondrogenic differentiation of human mesenchymal stem cells. J Pineal Res 56:62–70PubMedCrossRef
74.
García-Santos G, Martin V, Rodríguez-Blanco J et al (2012) Fas/Fas ligand regulation mediates cell death in human Ewing’s sarcoma cells treated with melatonin. Br J Cancer 106:1288–1296PubMedPubMedCentralCrossRef
75.
Garcia-Santos G, Rodriguez-Blanco J, Antolin I et al (2008) Antitumoral action of melatonin in Ewing sarcoma cells: possible EWS-FLI1 implication. Can Res 68:3757–3757
76.
Gilad E, Wong HR, Zingarelli B et al (1998) Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFkappaB activation. FASEB J: Off Publ Fed Am Soc Exp Biol 12:685–693CrossRef
77.
Gilbert L, He X, Farmer P et al (2000) Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 141:3956–3964PubMedCrossRef
78.
79.
Goldring SR (2003) Inflammatory mediators as essential elements in bone remodeling. Calcif Tissue Int 73:97–100PubMedCrossRef
80.
Gomathi K, Akshaya N, Srinaath N et al (2020) Regulation of Runx2 by post-translational modifications in osteoblast differentiation. Life Sci 245:117389PubMedCrossRef
81.
Gong Z, Da W, Tian Y et al (2022) Exogenous melatonin prevents type 1 diabetes mellitus-induced bone loss, probably by inhibiting senescence. Osteoporos Int: J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA 33:453–466CrossRef
82.
Greenwald RA (1991) Oxygen radicals, inflammation, and arthritis: pathophysiological considerations and implications for treatment. Semin Arthritis Rheum 20:219–240PubMedCrossRef
83.
Guan H, Kong N, Tian R et al (2022) Melatonin increases bone mass in normal, perimenopausal, and postmenopausal osteoporotic rats via the promotion of osteogenesis. J Transl Med 20:132PubMedPubMedCentralCrossRef
84.
Gumeniuk O, Stanislavchuk M, Ostapchuk O (2014) 193. Effect of melatonin on the severity of pain and quality of life in patients with osteoarthritis of the knee and hip. Rheumatology 53:i131–i132CrossRef
85.
Guntur AR, Kawai M, Le P et al (2011) An essential role for the circadian-regulated gene nocturnin in osteogenesis: the importance of local timekeeping in skeletal homeostasis. Ann N Y Acad Sci 1237:58–63PubMedPubMedCentralCrossRef
86.
Guo JY, Li F, Wen YB et al (2017) Melatonin inhibits Sirt1-dependent NAMPT and NFAT5 signaling in chondrocytes to attenuate osteoarthritis. Oncotarget 8:55967–55983PubMedPubMedCentralCrossRef
87.
Halıcı M, Öner M, Güney A et al (2010) Melatonin promotes fracture healing in the rat model. Eklem hastaliklari ve cerrahisi = Joint Dis Related Surg 21:172–177
88.
Han Y, Kim Y-M, Kim HS et al (2017) Melatonin promotes osteoblast differentiation by regulating Osterix protein stability and expression. Sci Rep 7:5716PubMedPubMedCentralCrossRef
89.
Hand LE, Dickson SH, Freemont AJ et al (2019) The circadian regulator Bmal1 in joint mesenchymal cells regulates both joint development and inflammatory arthritis. Arthritis Res Ther 21:5PubMedPubMedCentralCrossRef
90.
Hardeland R, Madrid JA, Tan DX et al (2012) Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling. J Pineal Res 52:139–166PubMedCrossRef
91.
Hardeland R, Pandi-Perumal SR, Cardinali DP (2006) Melatonin. Int J Biochem Cell Biol 38:313–316PubMedCrossRef
92.
Hardeland R, Rodríguez C (1995) Minireview: versatile melatonin: a pervasive molecule serves various functions in signaling and protection. Chronobiol Int 12:157–165CrossRef
93.
Henrotin Y, Kurz B, Aigner T (2005) Oxygen and reactive oxygen species in cartilage degradation: friends or foes? Osteoarthritis Cartilage 13:643–654PubMedCrossRef
94.
Hernandez RK, Adhia A, Wade SW et al (2015) Prevalence of bone metastases and bone-targeting agent use among solid tumor patients in the United States. Clin Epidemiol 7:335–345PubMedPubMedCentral
95.
Histing T, Anton C, Scheuer C et al (2012) Melatonin impairs fracture healing by suppressing RANKL-mediated bone remodeling. J Surg Res 173:83–90PubMedCrossRef
96.
97.
Hong Y, Kim H, Lee S et al (2017) Role of melatonin combined with exercise as a switch-like regulator for circadian behavior in advanced osteoarthritic knee. Oncotarget 8:97633–97647PubMedPubMedCentralCrossRef
98.
Hong Y, Kim H, Lee Y et al (2014) Salutary effects of melatonin combined with treadmill exercise on cartilage damage. J Pineal Res 57:53–66PubMedCrossRef
99.
Hosseini F, Shanehbandi D, Soleimanpour J et al (2022) Melatonin increases the sensitivity of osteosarcoma cells to chemotherapy drug cisplatin. Drug Res 72:312–318CrossRef
100.
Hu W, Liang JW, Liao S et al (2021) Melatonin attenuates radiation-induced cortical bone-derived stem cells injury and enhances bone repair in postradiation femoral defect model. Mil Med Res 8:61PubMedPubMedCentral
101.
Huang C, Liu J, Xia C et al (2010) Effects of melatonin on expression of bone morphogenetic protein 2 and interleukin 1beta in articular cartilage of rat with osteoarthritis. Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese J Reparative Reconstr Surg 24:1082–1087
102.
Huang CC, Chiou CH, Liu SC et al (2019) Melatonin attenuates TNF-α and IL-1β expression in synovial fibroblasts and diminishes cartilage degradation: implications for the treatment of rheumatoid arthritis. J Pineal Res 66:e12560PubMedCrossRef
103.
SaR H, Al-Khalifa II, Jasim NA et al (2011) Adjuvant use of melatonin for treatment of fibromyalgia. J Pineal Res 50:267–271CrossRef
104.
Inal ME, Kanbak G, Sunal E (2001) Antioxidant enzyme activities and malondialdehyde levels related to aging. Clin Chim Acta Int J Clin Chem 305:75–80CrossRef
105.
Ismaili L, Romero A, Carreiras MDC et al (2017) 2 — Multitarget-directed antioxidants as therapeutic agents: putting the focus on the oxidative stress. In: Decker M (ed) Design of hybrid molecules for drug development. Elsevier, p 5–46
106.
Jahanban-Esfahlan R, Mehrzadi S, Reiter RJ et al (2018) Melatonin in regulation of inflammatory pathways in rheumatoid arthritis and osteoarthritis: involvement of circadian clock genes. Br J Pharmacol 175:3230–3238PubMedCrossRef
107.
Jardim-Perassi BV, Arbab AS, Ferreira LC et al (2014) Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer. PLoS one 9:e85311PubMedPubMedCentralCrossRef
108.
Jeon MJ, Kim JA, Kwon SH et al (2003) Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts. J Biol Chem 278:23270–23277PubMedCrossRef
109.
Jeong H, Baek SY, Kim SW et al (2017) Comorbidities of rheumatoid arthritis: results from the Korean National Health and Nutrition Examination Survey. PLoS one 12:e0176260PubMedPubMedCentralCrossRef
110.
Jiang T, Xia C, Chen X et al (2019) Melatonin promotes the BMP9-induced osteogenic differentiation of mesenchymal stem cells by activating the AMPK/β-catenin signalling pathway. Stem Cell Res Ther 10:408PubMedPubMedCentralCrossRef
111.
Jimenez-Caliani AJ, Jimenez-Jorge S, Molinero P et al (2006) Sex-dependent effect of melatonin on systemic erythematosus lupus developed in Mrl/Mpj-Faslpr mice: it ameliorates the disease course in females, whereas it exacerbates it in males. Endocrinology 147:1717–1724PubMedCrossRef
112.
Jockers R, Maurice P, Boutin JA et al (2008) Melatonin receptors, heterodimerization, signal transduction and binding sites: what’s new? Br J Pharmacol 154:1182–1195PubMedPubMedCentralCrossRef
113.
Jones GT, Atzeni F, Beasley M et al (2015) The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheumatol 67:568–575PubMedCrossRef
114.
Kadenbach B, Ramzan R, Vogt S (2009) Degenerative diseases, oxidative stress and cytochrome c oxidase function. Trends Mol Med 15:139–147PubMedCrossRef
115.
Karamitri A, Jockers R (2019) Melatonin in type 2 diabetes mellitus and obesity. Nat Rev Endocrinol 15:105–125PubMedCrossRef
116.
Kawaguchi H, Akune T, Yamaguchi M et al (2005) Distinct effects of PPARgamma insufficiency on bone marrow cells, osteoblasts, and osteoclastic cells. J Bone Miner Metab 23:275–279PubMedCrossRef
117.
Ke C, Li H, Yang D et al (2022) Melatonin attenuates the progression of osteoarthritis in rats by inhibiting inflammation and related oxidative stress on the surface of knee cartilage. Orthop Surg 14:2230–2237PubMedPubMedCentralCrossRef
118.
Kim BK, Choi YJ, Chung YS (2013) Other than daytime working is associated with lower bone mineral density: the Korea National Health and Nutrition Examination Survey 2009. Calcif Tissue Int 93:495–501PubMedCrossRef
119.
Kim SS, Jeong SP, Park BS et al (2022) Melatonin attenuates RANKL-induced osteoclastogenesis via inhibition of Atp6v0d2 and DC-STAMP through MAPK and NFATc1 signaling pathways. Molecules 27:501
120.
Klerman EB, Goldenberg DL, Brown EN et al (2001) Circadian rhythms of women with fibromyalgia. J Clin Endocrinol Metab 86:1034–1039PubMed
121.
Kobayashi-Sun J, Suzuki N, Hattori A et al (2020) Melatonin suppresses both osteoblast and osteoclast differentiation through repression of epidermal Erk signaling in the zebrafish scale. Biochem Biophys Res Commun 530:644–650PubMedCrossRef
122.
Kong H, Wang X-Q, Zhang X-A (2022) Exercise for osteoarthritis: a literature review of pathology and mechanism. Front Aging Neurosci 14:854026
123.
Korszun A, Sackett-Lundeen L, Papadopoulos E et al (1999) Melatonin levels in women with fibromyalgia and chronic fatigue syndrome. J Rheumatol 26:2675–2680PubMed
124.
Köse D, Köse A, Halıcı Z et al (2020) Do peripheral melatonin agonists improve bone fracture healing? The effects of agomelatine and ramelteon on experimental bone fracture. Eur J Pharmacol 887:173577PubMedCrossRef
125.
Kotlarczyk MP, Lassila HC, O’neil CK et al (2012) Melatonin osteoporosis prevention study (MOPS): a randomized, double-blind, placebo-controlled study examining the effects of melatonin on bone health and quality of life in perimenopausal women. J Pineal Res 52:414–426PubMedCrossRef
126.
Kuhn A, Bonsmann G, Anders HJ et al (2015) The diagnosis and treatment of systemic lupus erythematosus. Deutsches Arzteblatt International 112:423–432PubMedPubMedCentral
127.
Lai M, Jin Z, Tang Q et al (2017) Sustained release of melatonin from TiO2 nanotubes for modulating osteogenic differentiation of mesenchymal stem cells in vitro. J Biomater Sci Polym Ed 28:1651–1664PubMedCrossRef
128.
129.
Lee S, Le NH, Kang D (2018) Melatonin alleviates oxidative stress-inhibited osteogenesis of human bone marrow-derived mesenchymal stem cells through AMPK activation. Int J Med Sci 15:1083–1091PubMedPubMedCentralCrossRef
130.
Li J, Li N, Chen Y et al (2019) SPRY4 is responsible for pathogenesis of adolescent idiopathic scoliosis by contributing to osteogenic differentiation and melatonin response of bone marrow-derived mesenchymal stem cells. Cell Death Dis 10:805PubMedPubMedCentralCrossRef
131.
Li M, Li Y, Deng W et al (2014) Chinese bone turnover marker study: reference ranges for C-terminal telopeptide of type I collagen and procollagen I N-terminal peptide by age and gender. PLoS one 9:e103841PubMedPubMedCentralCrossRef
132.
Li M, Yang N, Hao L et al (2022) Melatonin inhibits the ferroptosis pathway in rat bone marrow mesenchymal stem cells by activating the PI3K/AKT/mTOR signaling axis to attenuate steroid-induced osteoporosis. Oxid Med Cell Longev 2022:8223737PubMedPubMedCentral
133.
Li Y, Feng C, Gao M et al (2019) MicroRNA-92b-5p modulates melatonin-mediated osteogenic differentiation of bone marrow mesenchymal stem cells by targeting ICAM-1. J Cell Mol Med 23:6140–6153PubMedPubMedCentralCrossRef
134.
Li Y, Zou J, Li B et al (2021) Anticancer effects of melatonin via regulating lncRNA JPX-Wnt/β-catenin signalling pathway in human osteosarcoma cells. J Cell Mol Med 25:9543–9556PubMedPubMedCentralCrossRef
135.
Lian C, Wu Z, Gao B et al (2016) Melatonin reversed tumor necrosis factor-alpha-inhibited osteogenesis of human mesenchymal stem cells by stabilizing SMAD1 protein. J Pineal Res 61:317–327PubMedCrossRef
136.
Lim HD, Kim YS, Ko SH et al (2012) Cytoprotective and anti-inflammatory effects of melatonin in hydrogen peroxide-stimulated CHON-001 human chondrocyte cell line and rabbit model of osteoarthritis via the SIRT1 pathway. J Pineal Res 53:225–237PubMedCrossRef
137.
Liu-Bryan R, Pritzker K, Firestein GS et al (2005) TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J Immunol 174:5016–5023PubMedCrossRef
138.
Liu-Bryan R, Scott P, Sydlaske A et al (2005) Innate immunity conferred by toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal–induced inflammation. Arthritis Rheum 52:2936–2946PubMedCrossRef
139.
Liu CS, Tsai HL, Chin TW et al (2005) Surgical treatment of chylothorax caused by cardiothoracic surgery in children. J Chin Med Assoc : JCMA 68:234–236PubMedCrossRef
140.
Liu HD, Ren MX, Li Y et al (2022) Melatonin alleviates hydrogen peroxide induced oxidative damage in MC3T3-E1 cells and promotes osteogenesis by activating SIRT1. Free Radical Res 56:63–76CrossRef
141.
Liu L, Xu Y, Reiter RJ (2013) Melatonin inhibits the proliferation of human osteosarcoma cell line MG-63. Bone 55:432–438PubMedCrossRef
142.
Liu L, Xu Y, Reiter RJ et al (2016) Inhibition of ERK1/2 signaling pathway is involved in melatonin’s antiproliferative effect on human MG-63 osteosarcoma cells. Cell Physiol Biochem 39:2297–2307PubMedCrossRef
143.
Liu L, Xu Y, Reiter RJ et al (2016) Inhibition of ERK1/2 signaling pathway is involved in melatonin’s antiproliferative effect on human MG-63 osteosarcoma cells. Cell Physiol Biochem: Int J Exp Cell Physiol Biochem Pharmacol 39:2297–2307CrossRef
144.
Liu PI, Chang AC, Lai JL et al (2021) Melatonin interrupts osteoclast functioning and suppresses tumor-secreted RANKL expression: implications for bone metastases. Oncogene 40:1503–1515PubMedCrossRef
145.
Liu S-C, Tsai C-H, Wang Y-H et al (2022) Melatonin abolished proinflammatory factor expression and antagonized osteoarthritis progression in vivo. Cell Death Dis 13:215PubMedPubMedCentralCrossRef
146.
Liu W, Jiang H, Liu X et al (2022) Melatonin abates TMJOA chronic pain by MT(2)R in trigeminal ganglion neurons. J Dent Res 101:111–119PubMedCrossRef
147.
Liu X, Gong Y, Xiong K et al (2013) Melatonin mediates protective effects on inflammatory response induced by interleukin-1 beta in human mesenchymal stem cells. J Pineal Res 55:14–25PubMedCrossRef
148.
Liu Y, Liu Y, Zhang R et al (2014) All-trans retinoic acid modulates bone morphogenic protein 9-induced osteogenesis and adipogenesis of preadipocytes through BMP/Smad and Wnt/β-catenin signaling pathways. Int J Biochem Cell Biol 47:47–56PubMedCrossRef
149.
Lo J, Chan L, Flynn S (2021) A systematic review of the incidence, prevalence, costs, and activity and work limitations of amputation, osteoarthritis, rheumatoid arthritis, back pain, multiple sclerosis, spinal cord injury, stroke, and traumatic brain injury in the United States: a 2019 update. Arch Phys Med Rehabil 102:115–131PubMedCrossRef
150.
Long H, Liu Q, Yin H et al (2022) Prevalence trends of site‐specific osteoarthritis from 1990 to 2019: findings from the global burden of disease study 2019. Arthritis Rheumatol 74:1172–1183
151.
Lu KH, Su SC, Lin CW et al (2018) Melatonin attenuates osteosarcoma cell invasion by suppression of C-C motif chemokine ligand 24 through inhibition of the c-Jun N-terminal kinase pathway. J Pineal Res 65:e12507PubMedCrossRef
152.
Lu X, Yu S, Chen G et al (2021) Insight into the roles of melatonin in bone tissue and bone‑related diseases (review). Int J Mol Med 47:82
153.
154.
Lynch HJ, Wurtman RJ, Moskowitz MA et al (1975) Daily rhythm in human urinary melatonin. Science (New York, N.Y.) 187:169–171PubMedCrossRef
155.
Ma H, Wang X, Zhang W et al (2020) Melatonin suppresses ferroptosis induced by high glucose via activation of the Nrf2/HO-1 signaling pathway in type 2 diabetic osteoporosis. Oxid Med Cell Longev 2020:9067610PubMedPubMedCentralCrossRef
156.
Macdonald IJ, Huang CC, Liu SC et al (2020) Reconsidering the role of melatonin in rheumatoid arthritis. Int J Mol Sci 21:2877
157.
Macdonald IJ, Lin CY, Kuo SJ et al (2019) An update on current and future treatment options for chondrosarcoma. Expert Rev Anticancer Ther 19:773–786PubMedCrossRef
158.
159.
Manolagas SC, Jilka RL (1995) Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305–311PubMedCrossRef
160.
Mantle D, Smits M, Boss M et al (2020) Efficacy and safety of supplemental melatonin for delayed sleep–wake phase disorder in children: an overview. Sleep Med: X 2:100022PubMed
161.
Maria S, Samsonraj RM, Munmun F et al (2018) Biological effects of melatonin on osteoblast/osteoclast cocultures, bone, and quality of life: implications of a role for MT2 melatonin receptors, MEK1/2, and MEK5 in melatonin-mediated osteoblastogenesis. J Pineal Res 64. https://​doi.​org/​10.​1111/​jpi.​12465
162.
Maria S, Witt-Enderby PA (2014) Melatonin effects on bone: potential use for the prevention and treatment for osteopenia, osteoporosis, and periodontal disease and for use in bone-grafting procedures. J Pineal Res 56:115–125PubMedCrossRef
163.
Maronde E, Schilling AF, Seitz S et al (2010) The clock genes period 2 and cryptochrome 2 differentially balance bone formation. PLoS one 5:e11527PubMedPubMedCentralCrossRef
164.
Marques AP, Santo ADSDE, Berssaneti AA et al (2017) Prevalence of fibromyalgia: literature review update. Rev Bras Reumatol (English Edition) 57:356–363CrossRef
165.
Martinon F, Pétrilli V, Mayor A et al (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241PubMedCrossRef
166.
Matsuzaki T, Matsushita T, Takayama K et al (2014) Disruption of Sirt1 in chondrocytes causes accelerated progression of osteoarthritis under mechanical stress and during ageing in mice. Ann Rheum Dis 73:1397–1404PubMedCrossRef
167.
Mcclung MR, Geusens P, Miller PD et al (2001) Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 344:333–340PubMedCrossRef
168.
Mcelderry JD, Zhao G, Khmaladze A et al (2013) Tracking circadian rhythms of bone mineral deposition in murine calvarial organ cultures. J Bone Mineral Res : Off J Am Soc Bone Mineral Res 28:1846–1854CrossRef
169.
Mcinnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205–2219PubMedCrossRef
170.
Medrano-Campillo P, Sarmiento-Soto H, Álvarez-Sánchez N et al (2015) Evaluation of the immunomodulatory effect of melatonin on the T-cell response in peripheral blood from systemic lupus erythematosus patients. J Pineal Res 58:219–226PubMedCrossRef
171.
Mehrzadi S, Pourhanifeh MH, Mirzaei A et al (2021) An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress. Cancer Cell Int 21:1–28CrossRef
172.
Menczel Schrire Z, Phillips CL, Chapman JL et al (2022) Safety of higher doses of melatonin in adults: a systematic review and meta-analysis. J Pineal Res 72:e12782PubMedCrossRef
173.
Meunier PJ, Roux C, Seeman E et al (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459–468PubMedCrossRef
174.
175.
Min HY, Kim KM, Wee G et al (2016) Bmal1 induces osteoblast differentiation via regulation of BMP2 expression in MC3T3-E1 cells. Life Sci 162:41–46PubMedCrossRef
176.
Moffett SP, Zmuda JM, Oakley JI et al (2005) Tumor necrosis factor-alpha polymorphism, bone strength phenotypes, and the risk of fracture in older women. J Clin Endocrinol Metab 90:3491–3497PubMedCrossRef
177.
178.
179.
Munmun F, Witt-Enderby PA (2021) Melatonin effects on bone: implications for use as a therapy for managing bone loss. J Pineal Res 71:e12749PubMedCrossRef
180.
Murodumi H, Shigeishi H, Kato H et al (2020) Melatonin-induced miR-181c-5p enhances osteogenic differentiation and mineralization of human jawbone-derived osteoblastic cells. Mol Med Rep 22:3549–3558PubMed
181.
Nabatian-Asl M, Ghorbanihaghjo A, Malek Mahdavi A et al (2021) Effects of melatonin supplementation on serum oxidative stress markers and disease activity in systemic lupus erythematosus patients: a randomised, double-blind, placebo-controlled trial. Int J Clin Pract 75:e14246PubMedCrossRef
182.
Nabavi SM, Nabavi SF, Sureda A et al (2019) Anti-inflammatory effects of melatonin: a mechanistic review. Crit Rev Food Sci Nutr 59:S4-s16PubMedCrossRef
183.
Nah SS, Won HJ, Park HJ et al (2009) Melatonin inhibits human fibroblast-like synoviocyte proliferation via extracellular signal-regulated protein kinase/P21(CIP1)/P27(KIP1) pathways. J Pineal Res 47:70–74PubMedCrossRef
184.
Nataraj V, Rastogi S, Khan S et al (2016) Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients. Clin Transl Oncol 18:937–944PubMedCrossRef
185.
Niu G, Yousefi B, Qujeq D et al (2021) Melatonin and doxorubicin co-delivered via a functionalized graphene-dendrimeric system enhances apoptosis of osteosarcoma cells. Mater Sci Eng C Mater Biol Appl 119:111554PubMedCrossRef
186.
Oktem G, Uslu S, Vatansever SH et al (2006) Evaluation of the relationship between inducible nitric oxide synthase (iNOS) activity and effects of melatonin in experimental osteoporosis in the rat. Surg Radiol Anat : SRA 28:157–162PubMedCrossRef
187.
188.
Palmerini E, Picci P, Reichardt P et al (2019) Malignancy in giant cell tumor of bone: a review of the literature. Technol Cancer Res Treat 18:1533033819840000PubMedCrossRef
189.
190.
Parafioriti A, Cifola I, Gissi C et al (2020) Expression profiling of microRNAs and isomiRs in conventional central chondrosarcoma. Cell Death Discov 6:1–12CrossRef
191.
Park KH, Kang JW, Lee EM et al (2011) Melatonin promotes osteoblastic differentiation through the BMP/ERK/Wnt signaling pathways. J Pineal Res 51:187–194PubMedCrossRef
192.
Paulino Silva KM, De Sousa FL, Alves ACB et al (2021) Chondroprotective effect of melatonin and strontium ranelate in animal model of osteoarthritis. Heliyon 7:e06760PubMedPubMedCentralCrossRef
193.
Pei M, He F, Wei L et al (2009) Melatonin enhances cartilage matrix synthesis by porcine articular chondrocytes. J Pineal Res 46:181–187PubMedCrossRef
194.
Peress NS, Perillo E, Fenstermacher JD (1989) Circumventricular organs in chronic serum sickness: a model for cerebral lupus. Biol Psychiat 26:397–407PubMedCrossRef
195.
Pernambuco AP, Schetino LP, Viana RS et al (2015) The involvement of melatonin in the clinical status of patients with fibromyalgia syndrome. Clin Exp Rheumatol 33:S14-19PubMed
196.
Pines A (2016) Circadian rhythm and menopause. Climacteric : J Int Menopause Soc 19:551–552CrossRef
197.
Poeggeler B, Reiter RJ, Tan DX et al (1993) Melatonin, hydroxyl radical-mediated oxidative damage, and aging: a hypothesis. J Pineal Res 14:151–168PubMedCrossRef
198.
Press J, Phillip M, Neumann L et al (1998) Normal melatonin levels in patients with fibromyalgia syndrome. J Rheumatol 25:551–555PubMed
199.
Qin K, Tang H, Ren Y et al (2022) Melatonin promotes sirtuin 1 expression and inhibits IRE1α-XBP1S-CHOP to reduce endoplasmic reticulum stress-mediated apoptosis in chondrocytes. Front Pharmacol 13:940629PubMedPubMedCentralCrossRef
200.
Qiu X, Wang X, Qiu J et al (2019) Melatonin rescued reactive oxygen species-impaired osteogenesis of human bone marrow mesenchymal stem cells in the presence of tumor necrosis factor-alpha. Stem Cells Int 2019:6403967PubMedPubMedCentralCrossRef
201.
Qu H, Xue Y, Lian W et al (2018) Melatonin inhibits osteosarcoma stem cells by suppressing SOX9-mediated signaling. Life Sci 207:253–264PubMedCrossRef
202.
203.
Reiter RJ, Calvo JR, Karbownik M et al (2000) Melatonin and its relation to the immune system and inflammation. Ann N Y Acad Sci 917:376–386PubMedCrossRef
204.
Reiter RJ, Mayo JC, Tan DX et al (2016) Melatonin as an antioxidant: under promises but over delivers. J Pineal Res 61:253–278PubMedCrossRef
205.
Reiter RJ, Richardson BA, Hurlbut EC (1981) Pineal, retinal and Harderian gland melatonin in a diurnal species, the Richardson’s ground squirrel (Spermophilus richardsonii). Neurosci Lett 22:285–288CrossRef
206.
Reiter RJ, Sharma R, Rosales-Corral S et al (2022) Melatonin: a mitochondrial resident with a diverse skill set. Life Sci 30:1120612
207.
Reiter RJ, Tan DX, Maldonado MD (2005) Melatonin as an antioxidant: physiology versus pharmacology. J Pineal Res 39:215–216PubMedCrossRef
208.
Riggs BL, Wahner HW, Seeman E et al (1982) Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Investig 70:716–723PubMedPubMedCentralCrossRef
209.
Robeva R, Tanev D, Kirilov G et al (2013) Decreased daily melatonin levels in women with systemic lupus erythematosus — a short report. Balkan Med J 30:273–276PubMedPubMedCentralCrossRef
210.
211.
Rong J, Zhu M, Munro J et al (2019) Altered expression of the core circadian clock component PERIOD2 contributes to osteoarthritis-like changes in chondrocyte activity. Chronobiol Int 36:319–331PubMedCrossRef
212.
Rudra DS, Pal U, Maiti NC et al (2013) Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site. J Pineal Res 54:398–405PubMedCrossRef
213.
Sack RL, Lewy AJ, Erb DL et al (1986) Human melatonin production decreases with age. J Pineal Res 3:379–388PubMedCrossRef
214.
Saidenberg-Kermanac’h N, Cohen-Solal M, Bessis N et al (2004) Role for osteoprotegerin in rheumatoid inflammation. Joint Bone Spine 71:9–13PubMedCrossRef
215.
Sanchez-Sanchez AM, Antolin I, Puente-Moncada N et al (2015) Melatonin cytotoxicity is associated to Warburg effect inhibition in Ewing sarcoma cells. PLoS one 10:e0135420PubMedPubMedCentralCrossRef
216.
Sánchez-Sánchez AM, Turos-Cabal M, Puente-Moncada N et al (2022) Calcium acts as a central player in melatonin antitumor activity in sarcoma cells. Cell Oncol (Dordr) 45:415–428PubMedCrossRef
217.
Sasaki A, Taketomi T, Kato R et al (2003) Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1. Cell cycle (Georgetown, Tex.) 2:281–282PubMedCrossRef
218.
Scherer HU, Häupl T, Burmester GR (2020) The etiology of rheumatoid arthritis. J Autoimmun 110:102400PubMedCrossRef
219.
Schneider M (2009) EULAR recommendations for the management of systemic lupus erythematosus. Z Rheumatol 68(578):580–573
220.
Senel K, Baygutalp F, Baykal T et al (2013) Melatonin levels in premenopausal women with fibromyalgia syndrome. Rheumatol Int 33:1609–1610PubMedCrossRef
221.
Sethi S, Radio NM, Kotlarczyk MP et al (2010) Determination of the minimal melatonin exposure required to induce osteoblast differentiation from human mesenchymal stem cells and these effects on downstream signaling pathways. J Pineal Res 49:222–238PubMedCrossRef
222.
Shang J, Ma B, Zhu G et al (2020) Role of Zip1 in the regulation of NPY expression by MLT to promote fracture healing in rats. Eur J Histochem: EJH 64:3183
223.
Sheweita S, Khoshhal K (2007) Calcium metabolism and oxidative stress in bone fractures: role of antioxidants. Curr Drug Metab 8:519–525PubMedCrossRef
224.
Shino H, Hasuike A, Arai Y et al (2016) Melatonin enhances vertical bone augmentation in rat calvaria secluded spaces. Med Oral Patol Oral Cir Bucal 21:e122PubMedCrossRef
225.
Silva SO, Rodrigues MR, Ximenes VF et al (2004) Neutrophils as a specific target for melatonin and kynuramines: effects on cytokine release. J Neuroimmunol 156:146–152PubMedCrossRef
226.
Smolen JS, Aletaha D, Mcinnes IB (2016) Rheumatoid arthritis. Lancet (London, England) 388:2023–2038PubMedCrossRef
227.
Son J-H, Park B-S, Kim I-R et al (2017) A novel combination treatment to stimulate bone healing and regeneration under hypoxic conditions: photobiomodulation and melatonin. Lasers Med Sci 32:533–541PubMedCrossRef
228.
Sözen T, Özışık L, Başaran N (2017) An overview and management of osteoporosis. Eur J Rheumatol 4:46–56PubMedCrossRef
229.
Spahn G, Hofmann GO, Von Engelhardt LV et al (2013) The impact of a high tibial valgus osteotomy and unicondylar medial arthroplasty on the treatment for knee osteoarthritis: a meta-analysis. Knee Surg Sports Traumatol Arthrosc 21:96–112PubMedCrossRef
230.
Sulli A, Maestroni GJ, Villaggio B et al (2002) Melatonin serum levels in rheumatoid arthritis. Ann N Y Acad Sci 966:276–283PubMedCrossRef
231.
Sun X, Xie Z, Ma Y et al (2018) TGF-β inhibits osteogenesis by upregulating the expression of ubiquitin ligase SMURF1 via MAPK-ERK signaling. J Cell Physiol 233:596–606PubMedCrossRef
232.
Swanson CM, Kohrt WM, Buxton OM et al (2018) The importance of the circadian system & sleep for bone health. Metab: Clin Exp 84:28–43PubMedCrossRef
233.
Takaishi H, Kimura T, Dalal S et al (2008) Joint diseases and matrix metalloproteinases: a role for MMP-13. Curr Pharm Biotechnol 9:47–54PubMedCrossRef
234.
Takayama K, Ishida K, Matsushita T et al (2009) SIRT1 regulation of apoptosis of human chondrocytes. Arthritis Rheum 60:2731–2740PubMedCrossRef
235.
Takechi M, Tatehara S, Satomura K et al (2008) Effect of FGF-2 and melatonin on implant bone healing: a histomorphometric study. J Mater Sci - Mater Med 19:2949–2952PubMedCrossRef
236.
Tian Y, Gong Z, Zhao R et al (2021) Melatonin inhibits RANKL-induced osteoclastogenesis through the miR-882/Rev-erbα axis in Raw264.7 cells. Int J Mol Med 47:633–642PubMedCrossRef
237.
Tian Y, Ming J (2022) Melatonin inhibits osteoclastogenesis via RANKL/OPG suppression mediated by Rev-Erbα in osteoblasts. J Cell Mol Med 26:4032–4047PubMedPubMedCentralCrossRef
238.
Topal B, Çetin Altındal D, Gümüşderelioğlu M (2015) Melatonin/HPβCD complex: microwave synthesis, integration with chitosan scaffolds and inhibitory effects on MG-63CELLS. Int J Pharm 496:801–811PubMedCrossRef
239.
240.
Tuft C, Matar E, Menczel Schrire Z et al (2023) Current insights into the risks of using melatonin as a treatment for sleep disorders in older adults. Clin Interv Aging 18:49–59PubMedPubMedCentralCrossRef
241.
Vimalraj S, Saravanan S, Raghunandhakumar S et al (2020) Melatonin regulates tumor angiogenesis via miR-424-5p/VEGFA signaling pathway in osteosarcoma. Life Sci 256:118011PubMedCrossRef
242.
Vimalraj S, Selvamurugan N (2013) MicroRNAs: synthesis, gene regulation and osteoblast differentiation. Curr Issues Mol Biol 15:7–18PubMed
243.
Vriend J, Reiter RJ (2016) Melatonin, bone regulation and the ubiquitin-proteasome connection: a review. Life Sci 145:152–160PubMedCrossRef
244.
Wang B, Wen H, Smith W et al (2019) Regulation effects of melatonin on bone marrow mesenchymal stem cell differentiation. J Cell Physiol 234:1008–1015PubMedCrossRef
245.
Wang F, Zhou H, Du Z et al (2015) Cytoprotective effect of melatonin against hypoxia/serum deprivation-induced cell death of bone marrow mesenchymal stem cells in vitro. Eur J Pharmacol 748:157–165PubMedCrossRef
246.
247.
Wang X, Chen T, Deng Z et al (2021) Melatonin promotes bone marrow mesenchymal stem cell osteogenic differentiation and prevents osteoporosis development through modulating circ_0003865 that sponges miR-3653-3p. Stem Cell Res Ther 12:150PubMedPubMedCentralCrossRef
248.
Wang X, Liang T, Zhu Y et al (2019) Melatonin prevents bone destruction in mice with retinoic acid-induced osteoporosis. Mol Med (Cambridge, Mass.) 25:43
249.
Wang X, Su P, Kang Y et al (2021) Combination of melatonin and zoledronic acid suppressed the giant cell tumor of bone in vitro and in vivo. Front Cell Dev Biol 9:690502PubMedPubMedCentralCrossRef
250.
Wang Y, Li YP, Paulson C et al (2014) Wnt and the Wnt signaling pathway in bone development and disease. Front Biosci (Landmark edition) 19:379–407CrossRef
251.
Wang Y, Yang Z (2015) Effects of melatonin combined with Cis-platinum or methotrexate on the proliferation of osteosarcoma cell line SaOS-2. Zhongguo yi xue ke xue Yuan xue bao. Acta Acad Med Sinicae 37:215–220
252.
253.
Wikner J, Hirsch U, Wetterberg L et al (1998) Fibromyalgia—a syndrome associated with decreased nocturnal melatonin secretion. Clin Endocrinol 49:179–183CrossRef
254.
Witt-Enderby PA, Radio NM, Doctor JS et al (2006) Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy. J Pineal Res 41:297–305PubMedCrossRef
255.
Wu A-M, Bisignano C, James SL et al (2021) Global, regional, and national burden of bone fractures in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet Health Longev 2:e580–e592CrossRef
256.
Xiao L, Lin J, Chen R et al (2020) Sustained release of melatonin from GelMA liposomes reduced osteoblast apoptosis and improved implant osseointegration in osteoporosis. Oxid Med Cell Longev 2020:6797154PubMedPubMedCentralCrossRef
257.
Xiao W-Z, Zhao L, Cao L et al (2021) Melatonin alleviates acute gouty inflammation in vivo and in vitro. Curr Med Sci 41:757–763PubMedCrossRef
258.
Xiao WZ, Zhao L, Cao L et al (2021) Melatonin alleviates acute gouty inflammation in vivo and in vitro. Curr Med Sci 41:757–763PubMedCrossRef
259.
Xie Y, Han N, Li F et al (2022) Melatonin enhances osteoblastogenesis of senescent bone marrow stromal cells through NSD2-mediated chromatin remodelling. Clin Transl Med 12:e746PubMedPubMedCentralCrossRef
260.
Xu L, Zhang L, Wang Z et al (2018) Melatonin suppresses estrogen deficiency-induced osteoporosis and promotes osteoblastogenesis by inactivating the NLRP3 inflammasome. Calcif Tissue Int 103:400–410PubMedCrossRef
261.
Yang C, Kang F, Huang X et al (2022) Melatonin attenuates bone cancer pain via the SIRT1/HMGB1 pathway. Neuropharmacology 220:109254PubMedCrossRef
262.
Yildirimturk S, Batu S, Alatli C et al (2016) The effects of supplemental melatonin administration on the healing of bone defects in streptozotocin-induced diabetic rats. J Appl Oral Sci 24:239–249PubMedPubMedCentralCrossRef
263.
Yildirimturk S, Batu S, Alatli C et al (2016) The effects of supplemental melatonin administration on the healing of bone defects in streptozotocin-induced diabetic rats. J Appl Oral Sci : Rev FOB 24:239–249CrossRef
264.
Yildiz BS, Sahin A, Aladag NB et al (2015) Association of endogenous melatonin with uric acid and traditional cardiovascular risk factors in healthy young male. Adv Clin Exp Med 24:233–237PubMedCrossRef
265.
Yu C, Gershwin ME, Chang C (2014) Diagnostic criteria for systemic lupus erythematosus: a critical review. J Autoimmun 48–49:10–13PubMedCrossRef
266.
Zhang J, Jia G, Xue P et al (2021) Melatonin restores osteoporosis-impaired osteogenic potential of bone marrow mesenchymal stem cells and alleviates bone loss through the HGF/PTEN/Wnt/β-catenin axis. Ther Adv Chronic Dis 12:2040622321995685PubMedPubMedCentralCrossRef
267.
Zhang L, Su P, Xu C et al (2010) Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARγ expression and enhancing Runx2 expression. J Pineal Res 49:364–372PubMedCrossRef
268.
Zhang W, Zhao W, Li Q et al (2021) 3D-printing magnesium-polycaprolactone loaded with melatonin inhibits the development of osteosarcoma by regulating cell-in-cell structures. J Nanobiotechnology 19:263PubMedPubMedCentralCrossRef
269.
270.
Zhang Y, Hou M, Liu Y et al (2022) Recharge of chondrocyte mitochondria by sustained release of melatonin protects cartilage matrix homeostasis in osteoarthritis. J Pineal Res 73:e12815PubMedCrossRef
271.
Zhang Y, Lin J, Zhou X et al (2019) Melatonin prevents osteoarthritis-induced cartilage degradation via targeting microRNA-140. Oxid Med Cell Longev 2019:9705929PubMedPubMedCentralCrossRef
272.
Zhang Y, Liu T, Yang H et al (2022) Melatonin: a novel candidate for the treatment of osteoarthritis. Ageing Res Rev 78:101635PubMedCrossRef
273.
Zhang Z, Lin J, Tian N et al (2019) Melatonin protects vertebral endplate chondrocytes against apoptosis and calcification via the Sirt1-autophagy pathway. J Cell Mol Med 23:177–193PubMedCrossRef
274.
Zhao C-N, Wang P, Mao Y-M et al (2019) Potential role of melatonin in autoimmune diseases. Cytokine Growth Factor Rev 48:1–10PubMedCrossRef
275.
Zhao J, Yue W, Zhu MJ et al (2010) AMP-activated protein kinase (AMPK) cross-talks with canonical Wnt signaling via phosphorylation of beta-catenin at Ser 552. Biochem Biophys Res Commun 395:146–151PubMedPubMedCentralCrossRef
276.
Zhao K, Zhao Q, Guo Z et al (2018) Hsa_Circ_0001275: a potential novel diagnostic biomarker for postmenopausal osteoporosis. Cell Physiol Biochem : Int J Exp Cell Physiol Biochem Pharmacol 46:2508–2516CrossRef
277.
Zhao M, Song X, Chen H et al (2022) Melatonin prevents chondrocyte matrix degradation in rats with experimentally induced osteoarthritis by inhibiting nuclear factor-κB via SIRT1. Nutrients 14:3966
278.
Zhao R, Tao L, Qiu S et al (2020) Melatonin rescues glucocorticoid-induced inhibition of osteoblast differentiation in MC3T3-E1 cells via the PI3K/AKT and BMP/Smad signalling pathways. Life Sci 257:118044PubMedCrossRef
279.
Zhdanova IV, Lynch HJ, Wurtman RJ (1997) Melatonin: a sleep-promoting hormone. Sleep 20:899–907PubMed
280.
Zheng S, Zhou C, Yang H et al (2022) Melatonin accelerates osteoporotic bone defect repair by promoting osteogenesis-angiogenesis coupling. Front Endocrinol (Lausanne) 13:826660PubMedCrossRef
281.
Zhou L-L, Wei W, Si J-F et al (2010) Regulatory effect of melatonin on cytokine disturbances in the pristane-induced lupus mice. Mediators Inflamm 2010:951210PubMedPubMedCentralCrossRef
282.
Zhou L, Chen X, Yan J et al (2017) Melatonin at pharmacological concentrations suppresses osteoclastogenesis via the attenuation of intracellular ROS. Osteoporos Int: J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA 28:3325–3337CrossRef
283.
Zhou M, Qin S, Chu Y et al (2014) Immunolocalization of MMP-2 and MMP-9 in human rheumatoid synovium. Int J Clin Exp Pathol 7:3048–3056PubMedPubMedCentral
284.
Zhou X, Zhang Y, Hou M et al (2022) Melatonin prevents cartilage degradation in early-stage osteoarthritis through activation of miR-146a/NRF2/HO-1 axis. J Bone Mineral Res : Off J Am Soc Bone Mineral Res 37:1056–1072CrossRef
285.
Zhu G, Ma B, Dong P et al (2020) Melatonin promotes osteoblastic differentiation and regulates PDGF/AKT signaling pathway. Cell Biol Int 44:402–411PubMedCrossRef
286.
Zisapel N (2001) Circadian rhythm sleep disorders: pathophysiology and potential approaches to management. CNS Drugs 15:311–328PubMedCrossRef
287.
Zvonic S, Ptitsyn AA, Kilroy G et al (2007) Circadian oscillation of gene expression in murine calvarial bone. J Bone Mineral Res: Off J Am Soc Bone Mineral Res 22:357–365CrossRef
Metadaten
Titel
Melatonin and bone-related diseases: an updated mechanistic overview of current evidence and future prospects
verfasst von
Abolfazl Bagherifard
Azam Hosseinzadeh
Fereshteh Koosha
Mohammad Sheibani
Arman Karimi-Behnagh
Russel J. Reiter
Saeed Mehrzadi
Publikationsdatum
02.07.2023
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 10/2023
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-023-06836-1

Weitere Artikel der Ausgabe 10/2023

Osteoporosis International 10/2023 Zur Ausgabe

Original Article

Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise

Review

The effect of intermittent parathyroid hormone on bone lengthening: current evidence to inform future effective interventions

Letter to the Editor

Author response to: Comment on: Abdalbary et al. Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study

Letter to the Editor

Atypical femoral fracture after denosumab for the treatment of osteoporosis in bisphosphonate naïve patients: two further cases

Letter to the Editor

Response letter to: “The importance of structural barriers of osteoporotic hip fracture in the elderly”

Short Communication

Liver enzyme inducing anticonvulsant drug use is associated with prevalent vertebral fracture

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise